Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Pfizer Inc

PFE
Current price
28.3 USD -0.5 USD (-1.74%)
Last closed 28.88 USD
Sector Healthcare
Industry Drug Manufacturers - General
Exchange NYSE
Capitalization 163 651 125 248 USD
Yield for 12 month -23.53 %
1Y
3Y
5Y
10Y
15Y
PFE
21.11.2021 - 28.11.2021

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Address: 66 Hudson Boulevard East, New York, NY, United States, 10001-2192

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

31.48 USD

P/E ratio

Dividend Yield

5.82 %

Current Year

+58 496 000 000 USD

Last Year

+100 330 000 000 USD

Current Quarter

+14 879 000 000 USD

Last Quarter

+14 249 000 000 USD

Current Year

+29 283 000 000 USD

Last Year

+65 986 000 000 USD

Current Quarter

+10 498 000 000 USD

Last Quarter

+5 657 000 000 USD

Key Figures PFE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 9 621 000 192 USD
Operating Margin TTM 31.63 %
PE Ratio
Return On Assets TTM 0.93 %
PEG Ratio 0.256
Return On Equity TTM -0.26 %
Wall Street Target Price 31.48 USD
Revenue TTM 54 889 000 960 USD
Book Value 16.28 USD
Revenue Per Share TTM
Dividend Share 1.65 USD
Quarterly Revenue Growth YOY -19.5 %
Dividend Yield 5.82 %
Gross Profit TTM 66 233 000 000 USD
Earnings per share -0.05 USD
Diluted Eps TTM -0.05 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -43.4 %
Profit Margin -0.56 %

Dividend Analytics PFE

Champion - 10+ consecutive years of dividend increases

Dividend growth over 5 years

27 %

Continuous growth

13 years

Payout Ratio 5 years average

135 %

Dividend History PFE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.68
Ex Dividend Date 09.05.2024
Forward Annual Dividend Yield 5.82 %
Last Split Factor 1054:1000
Payout Ratio 116.9 %
Last Split Date 17.11.2020
Dividend Date 14.06.2024

Stock Valuation PFE

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 11.6686
Enterprise Value Revenue 3.4975
Price Sales TTM 2.5033
Enterprise Value EBITDA 21.4072
Price Book MRQ 1.6451

Financials PFE

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PFE

For 52 weeks

24.83 USD 38.23 USD
50 Day MA 27.28 USD
Shares Short Prior Month 68 062 599
200 Day MA 29.69 USD
Short Ratio 1.6
Shares Short 70 223 845
Short Percent 1.24 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds


S

SX7EEX

14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics

Metals


Gold

2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics